Silencing of the DEK gene induces apoptosis and senescence in CaSki cervical carcinoma cells via the up-regulation of NF-κB p65

Bioscience Reports

Volumn 32, Issue 3, 2012, Pages 323-332

  Liu, Kuiran ^a   Feng, Tianda ^a   Liu, Jie ^a   Zhong, Ming ^a   Zhang, Shulan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cervical cancer; DEK; Nuclear factor B (NF B); Senescence; Small interfering RNA

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BETA GALACTOSIDASE; CELL PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; LIPOFECTAMINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPIDIUM IODIDE; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE G0 PHASE; CELL LYSATE; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOSOLIC FRACTION; DEK GENE; DNA BINDING; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; I KAPPA B ALPHA GENE; M PHASE CELL CYCLE CHECKPOINT; PROTEIN EXPRESSION; PROTO ONCOGENE; SENESCENCE; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CARCINOMA;

APOPTOSIS; CARCINOMA; CELL AGING; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; I-KAPPA B PROTEINS; ONCOGENE PROTEINS; PROTEIN TRANSPORT; RNA INTERFERENCE; TRANSCRIPTION FACTOR RELA; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84859456711     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20100141     Document Type: Article

References (30)

1. Collado, M., Blasco, M. A. and Serrano, M. (2007) Cellular senescence in cancer and aging. Cell 130, 223-233 (Pubitemid 47081143)
2. Wise-Draper, T. M., Allen, H. V., Jones, E. E., Habash, K. B., Matsuo, H. and Wells, S. I. (2006) Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions. Mol. Cell. Biol. 26, 7506-7519 (Pubitemid 44547701)
3. Wise-Draper, T. M., Allen, H. V., Thobe, M. N., Jones, E. E., Habash, K. B., Munger, K. and Wells, S. I. (2005) The human DEK proto-oncogene is a senescence inhibitor and an up-regulated target of high-risk human papillomavirus E7. J. Virol. 79, 14309-14317 (Pubitemid 41552728)
4. Wells, S. I., Aronow, B. J., Wise, T. M., Williams, S. S., Couget, J. A. and Howley, P. M. (2003) Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100, 7093-7098 (Pubitemid 36706398)
5. Kim, D. W., Chae, J. I., Kim, J. Y., Pak, J. H., Koo, D. B., Bahk, Y. Y. and Seo, S. B. (2009) Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK. J. Cell. Biochem. 106, 1048-1059
6. Alexiadis, V., Waldmann, T., Andersen, J., Mann, M., Knippers, R. and Gruss, C. (2000) The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes. Dev. 14, 1308-1312 (Pubitemid 30397074)
7. Ch'en, I. L., Hedrick, S. M. and Hoffmann, A. (2008) NF-κB as a determinant of distinct cell death pathways. Methods Enzymol. 446, 175-187
8. Prusty, B. K., Husain, S. A. and Das, B. C. (2005) Constitutive activation of nuclear factor κB:preferential homodimerization of p50 subunits in cervical carcinoma. Front. Biosci. 10, 1510-1519 (Pubitemid 40529016)
9. Ko, S. I., Lee, I. S., Kim, J. Y., Kim, S. M., Kim, D. W., Lee, K. S., Woo, K. M., Baek, J. H., Choo, J. K. and Seo, S. B. (2006) Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK. FEBS Lett. 580, 3217-3222
10. Waldmann, T., Eckerich, C., Baack, M. and Gruss, C. (2002) The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils. J. Biol. Chem. 277, 24988-24994 (Pubitemid 34951801)
11. Wichmann, I., Respaldiza, N., Garcia-Lozano, J. R., Montes, M., Sanchez-Roman, J. and Nunez-Roldan, A. (2000) Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 119, 530-532 (Pubitemid 30146351)
12. Münger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M. and Huh, K. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78, 11451-11460 (Pubitemid 39390733)
13. Clifford, G. M., Smith, J. S., Plummer, M., Munoz, N. and Franceschi, S. (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta analysis. Br. J. Cancer 88, 63-73
14. Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. and Meijer, C. J. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348, 518-527 (Pubitemid 36159887)
15. Wu, Q., Li, Z., Lin, H., Han, L., Liu, S. and Lin, Z. (2008) DEK overexpression in uterine cervical cancers. Pathol. Int. 58, 378-382 (Pubitemid 351677540)
16. Shibata, T., Kokubu, A., Miyamoto, M., Hosoda, F., Gotoh, M., Tsuta, K., Asamura, H., Matsuno, Y., Kondo, T., Imoto, I. et al. (2010) DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung. Oncogene 29, 4671-4681
17. Riveiro-Falkenbach, E. and Soengas, MS. (2010) Control of tumorigenesis and chemoresistance by the DEK oncogene. Clin. Cancer. Res. 16, 2932-2938
18. Feng, W., Xiao, J., Zhang, Z., Rosen, D. G., Brown, R. E., Liu, J. and Duan, X. (2007) Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma. Mod. Pathol. 20, 961-966 (Pubitemid 47267824)
19. Elbashir, S. M., Harborth, J., Weber, K. and Tuschl, T. (2002) Analysis of gene unction in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213 (Pubitemid 34969582)
20. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (Pubitemid 32494397)
21. Karin, M., Cao, Y., Greten, F. R. and Li, Z. W. (2002) NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2, 301-310 (Pubitemid 37328783)
22. Basak, S. and Hoffmann, A. (2008) Crosstalk via the NF-κB signaling system. Cytokine Growth Factor Rev. 19, 187-197
23. Gosselin, K. and Abbadie, C. (2003) Involvement of a Rel/NF-κB transcription factors in senescence. Exp. Gerontol. 38, 1271-1283 (Pubitemid 38041214)
24. Ramdass, B., Maliekal, T. T., Lakshmi, S., Rehman, M., Rema, P., Nair, P., Mukherjee, G., Reddy, B. K., Krishna, S. and Radhakrishna Pillai, M. (2007) Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression. Gynecol. Oncol. 104, 352-361 (Pubitemid 46135657)
25. Nair, A., Venkatraman, M., Maliekal, T. T., Nair, B. and Karunagaran, D. (2003) NF-κB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22, 50-58 (Pubitemid 36152883)
26. Hollenbach, A. D., McPherson, C. J., Mientjes, E. J., Iyengar, R. and Grosveld, G. (2002) Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J. Cell Sci. 115, 3319-3330 (Pubitemid 34960184)
27. Khodadoust, M. S., Verhaegen, M., Kappes, F., Riveiro-Falkenbach, E., Cigudosa, J. C., Kim, D. S., Chinnaiyan, A. M., Markovitz, D. M. and Soengas, M. S. (2009) Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res. 69, 6405-6413
28. Campillos, M., Garcia, M. A., Valdivieso, F. and Vazquez, J. (2003) Transcriptional activation by AP-2α is modulated by the oncogene DEK. Nucleic Acids Res. 31, 1571-1575 (Pubitemid 36304919)
29. Carro, M. S., Spiga, F. M., Quarto, M., Dininni, V., Volorio, S., Alcalay, M. and Muller, H. (2006) DEK expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle 51, 202-1207
30. Sammons, M., Wan, S. S., Vogel, N. L., Mientjes, E. J., Grosveld, G. and Ashburner, B. P. (2006) Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene. J. Biol. Chem. 281, 26802-26812 (Pubitemid 44401709)